Standard BioTools Inc. Goodwill, Foreign Currency Translation Gain (Loss)
Standard BioTools Inc. (LAB) reported Goodwill, Foreign Currency Translation Gain (Loss) of $86.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-06.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2025-05-06
- Standard BioTools Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-03-31 was $86.00K.
- Standard BioTools Inc. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-12-31 was -$155.00K.
- Standard BioTools Inc. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$130.00K, a 296.97% decline from fiscal 2023.
- Standard BioTools Inc. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $66.00K.
- Standard BioTools Inc. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$128.00K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-03-31 | $86.00K 10-Q · filed 2025-05-06 | -$69.00K derived: sum of 2 quarters · filed 2025-05-06 | ||
| 2024-12-31 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$130.00K 10-K · filed 2025-03-11 | ||
| 2024-09-30 | $25.00K 10-Q · filed 2024-11-06 | |||
| 2023-12-31 | $66.00K 10-K · filed 2025-03-11 | |||
| 2022-12-31 | -$128.00K 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |